CAR T Cells Targeting GD2 Feasible, Safe for Pediatric Neuroblastoma
THURSDAY, April 6, 2023 (HealthDay News) -- Chimeric antigen receptor (CAR)-expressing T cells that target the disialoganglioside GD2 expressed on tumor cells (GD2-CAR T cells) are feasible and safe for children with heavily pretreated neuroblastoma, according to a study published in the April 6 issue of the New England Journal of Medicine.
Francesca Del Bufalo, M.D., from IRCCS Ospedale Pediatrico Bambino Gesù in Rome, and colleagues conducted a phase 1/2 clinical trial involving 27 children with heavily pretreated neuroblastoma (12 with refractory disease, 14 with relapsed disease, and one with a complete response at the end of first-line therapy) who received GD2-CAR T cells expressing the inducible caspase 9 suicide gene (GD2-CART01).
The researchers observed no failure to generate GD2-CART01. In the phase 1 part of the trial, three dose levels were tested (3-, 6-, and 10x106 CAR-positive T cells/kg body weight), with no dose-limiting toxic effects reported. For the phase 2 part of the trial, the recommended dose was 10x106 CAR-positive T cells/kg. In 74 percent of patients, cytokine release syndrome occurred and was mild in all but one patient. The suicide gene was activated in one patient, with rapid elimination of GD2-CART01. GD2-targeted CAR T cells expanded in vivo; up to 30 months after infusion, they were detectable in peripheral blood in 26 of 27 patients. Overall response was 63 percent, with nine and eight patients having a complete and partial response, respectively. Three-year overall survival and event-free survival were 60 and 36 percent, respectively, among children receiving the recommended dose.
"GD2-CART01 may induce sustained eradication of disease in a proportion of patients with relapsed or refractory neuroblastoma," the authors write.
Bellicum Pharmaceuticals donated rimiducid for the trial.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Risk for GI Disorders Increased After Acute Phase of COVID-19
MONDAY, March 27, 2023 (HealthDay News) -- People with severe acute respiratory...
AHA News: NFL Player’s Cardiac Arrest Was a Triggering, Traumatic Event for Many
WEDNESDAY, Jan. 4, 2023 (American Heart Association News) -- When Damar Hamlin's...
Usar pantallas poco antes de la hora de acostarse es malo para el sueño de los niños en edad preescolar
LUNES, 31 de enero de 2022 (HealthDay News) -- Es esencial mantener a los niños...